Table of Contents
Volume 4 | Supplement 2
Publication Date: October 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S54 |
Anti–Vascular Endothelial Growth Factor Therapy: Sharpening Our Tools for the Treatment of Metastatic Colorectal Cancer Lee M. Ellis |
|
Contributions | ||
S55-S61 |
Preclinical Data Targeting Vascular Endothelial Growth Factor in Colorectal Cancer Lee M. Ellis |
|
S62-S68 |
Integrating the Anti–VEGF-A Humanized Monoclonal Antibody Bevacizumab with Chemotherapy in Advanced Colorectal Cancer Herbert Hurwitz |
|
S69-S73 |
Can Inhibition of Angiogenic Pathways Increase the Efficacy of Intravenous 5-Fluorouracil–Based Regimens? Fairooz F. Kabbinavar, Lee M. Ellis |
|
S74-S80 |
Combining Anti-VEGF Approaches with Oxaliplatin in Advanced Colorectal Cancer Shannon K. Penland, Richard M. Goldberg |
|
S81-S85 |
Use of Soluble Recombinant Decoy Receptor Vascular Endothelial Growth Factor Trap (VEGF Trap) to Inhibit Vascular Endothelial Growth Factor Activity Jason Konner, Jakob Dupont |
|
S86-S93 |
Future Directions with Angiogenesis Inhibitors in Colorectal Cancer Joshua H. Bilenker, Daniel G. Haller |
|